Clinical Trial Update: Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients [Phase 2]

View source ↗

Summary

Phase 2 exploratory trial evaluating basiliximab for pulmonary cytokine storm in hospitalized adults with SARS-CoV-2 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytokine Storm
• Sars-cov-2 Acute Respiratory Disease

Drugs mentioned

• Basiliximab (basiliximab)

Snippet

Sponsor: Fort Worth Clinical Sciences Working Group | Conditions: SARS-CoV-2 Acute Respiratory Disease, SARS-CoV2 Infection | Phase 2 | Status: UNKNOWN